We are live on ! Find out more

499 hedge funds and large institutions have $11.4B invested in Sanofi in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 158 increasing their positions, 184 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $26.7M | Put options by funds: $11.5M

79% more funds holding in top 10

Funds holding in top 10: 1425 (+11)

0% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 38

0% less funds holding

Funds holding: 501499 (-2)

0.92% less ownership

Funds ownership: 19.31%18.38% (-0.92%)

9% less capital invested

Capital invested by funds: $12.5B → $11.4B (-$1.07B)

14% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 184

Holders
499
Holders Change
-2
Holders Change %
-0.4%
% of All Funds
13.93%
Holding in Top 10
25
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+78.57%
% of All Funds
0.7%
New
38
Increased
158
Reduced
184
Closed
38
Calls
$26.7M
Puts
$11.5M
Net Calls
+$15.2M
Net Calls Change
+$1.65M

SNY Hedge Fund Activity: Q3 2015 in Review

499 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2015, worth a combined $11.4B — down 8.5% from $12.5B a quarter earlier.

Fund positioning in SNY was balanced in Q3 2015: 38 funds opened new positions, 38 closed out, 158 added to existing stakes and 184 trimmed.

The largest buyer was Bank of America, adding an estimated $112M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $84.8M.

  • 499 institutional investors held Sanofi (SNY) as of Q3 2015, down from 501 in Q2 2015.
  • Funds reported $11.4B of Sanofi stock for Q3 2015, down 8.5% quarter-over-quarter.
  • 38 funds opened new Sanofi positions in Q3 2015 and 38 closed out, a net change of 0 holders.
  • The largest Sanofi buyer in Q3 2015 was Bank of America, an estimated $112M added.
  • The largest Sanofi seller in Q3 2015 was Hotchkis & Wiley Capital Management, an estimated $84.8M sold.

Based on aggregated 13F filings for Q3 2015.